Keitaro Yoshimoto

Dr. Keitaro Yoshimoto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
KWKoji Wakui
Koji Wakui
TYToru Yoshitomi
Toru Yoshitomi
AYAkane Yamaguchi
Akane Yamaguchi
MTMaho Tsuchida
Maho Tsuchida
SSShingo Saito
Shingo Saito
KYKeitaro Yoshimoto
Keitaro Yoshimoto
We present a rapidly neutralizable and highly anticoagulant thrombin-binding aptamer with a short toehold sequence, originally discovered by systematic evolution of ligands by exponential enrichment (SELEX) with microbead-assisted capillary electrophoresis (MACE). MACE is a novel CE-partitioning method for SELEX and able to separate aptamers from a library of unbound nucleic acids, where the aptamer and target complexes can be detected reliably and partitioned with high purity even in the first selection cycle. Three selection rounds of MACE-SELEX discovered several TBAs with a nanomolar affinity (Kd = 4.5-8.2 nM) that surpasses previously reported TBAs such as HD1, HD22, and NU172 (Kd = 118, 13, and 12 nM, respectively). One of the obtained aptamers, M08, showed a 10- to 20-fold longer prolonged clotting time than other anticoagulant TBAs, such as HD1, NU172, RE31, and RA36. Analyses of the aptamer and thrombin complexes using both bare and coated capillaries suggested that a large number of efficient aptamers are missed in conventional CE-SELEX because of increased interaction between the complex and the capillary. In addition, the toehold-mediated rapid antidote was designed for safe administration. The efficient aptamer and antidote system developed in the present study could serve as a new candidate for anticoagulant therapy.

1 March 2020 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
TYToru Yoshitomi
Toru Yoshitomi
MHMisako Hayashi
Misako Hayashi
TOTakumi Oguro
Takumi Oguro
KKKeiko Kimura
Keiko Kimura
FWFumiya Wayama
Fumiya Wayama
KYKeitaro Yoshimoto
Keitaro Yoshimoto
Vascular endothelial growth factors (VEGFs) are hypoxia-inducible secreted proteins to promote angiogenesis, in which VEGF-A is an important molecule that binds and activates VEGF receptor-1 (VEGFR-1) and VEGFR-2. In this study, two DNA aptamers, Apt01 and Apt02, were successfully isolated by alternating consecutive systematic evolution of ligands by exponential enrichment (SELEX) against VEGFR-1 and -2 using deep sequencing analysis in an early selection round. Their binding affinities for VEGFR-2 were lower than that of VEGFR-1, which is similar to that of VEGF-A. Structural analyses with the measurements of circular dichroism spectra and ultraviolet melting curve showed that Apt01 possessed the stem-loop structure in the molecule, whereas Apt02 formed G-quadruplex structures. In addition, Apt02 accelerated a tube formation of human umbilical vein endothelial cells faster than Apt01, which was affected by difference of binding affinity and nuclease resistance due to G-quadruplex structures. These results demonstrated that Apt02 might have a potential to function as an alternative to VEGF-A.

30 June 2015 in Chemical Science
Verified
Journal Article
Open access
PDF file
STShunsuke Tomita
Shunsuke Tomita
MSMiho Sakao
Miho Sakao
Ryoji KuritaRyoji Kurita
Ryoji Kurita
ONOsamu Niwa
Osamu Niwa
KYKeitaro Yoshimoto
Keitaro Yoshimoto
A sensor array of cross-reactive polyion complexes enabled markerless and noninvasive identification of osteogenic and adipogenic differentiation of human mesenchymal stem cells.

7 November 2017 in ACS Synthetic Biology
Verified
Journal Article
Closed access
YFYuichi Furuhata
Yuichi Furuhata
YNYuta Nihongaki
Yuta Nihongaki
MSMoritoshi Sato
Moritoshi Sato
KYKeitaro Yoshimoto
Keitaro Yoshimoto

1 August 2018 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
HZHangyu Zheng
Hangyu Zheng
TYToru Yoshitomi
Toru Yoshitomi
KYKeitaro Yoshimoto
Keitaro Yoshimoto

28 July 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Romualdo TroisiRomualdo Troisi
Romualdo Troisi
VNValeria Napolitano
Valeria Napolitano
EREmanuele Rossitto
Emanuele Rossitto
WOWaleed Osman
Waleed Osman
MNMasanobu Nagano
Masanobu Nagano
FSFilomena Sica
Filomena Sica
Ligand/protein molecular recognition involves a dynamic process, whereby both partners require a degree of structural plasticity to regulate the binding/unbinding event. Here, we present the characterization of the interaction between a highly dynamic G-rich oligonucleotide, M08s-1, and its target protein, human α-thrombin. M08s-1 is the most active anticoagulant aptamer selected thus far. Circular dichroism and gel electrophoresis analyses indicate that both intramolecular and intermolecular G-quadruplex structures are populated in solution. The presence of thrombin stabilises the antiparallel intramolecular chair-like G-quadruplex conformation, that provides by far the main contribution to the biological activity of the aptamer. The crystal structure of the thrombin-oligonucleotide complex reveals that M08s-1 adopts a kinked structural organization formed by a G-quadruplex domain and a long duplex module, linked by a stretch of five purine bases. The quadruplex motif hooks the exosite I region of thrombin and the duplex region is folded towards the surface of the protein. This structural feature, which has never been observed in other anti-exosite I aptamers with a shorter duplex motif, hinders the approach of a protein substrate to the active site region and may well explain the significant increase in the anticoagulant activity of M08s-1 compared to the other anti-exosite I aptamers.